ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 12, 1990

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975